About Krueppel-like factor 1
Krueppel-like factor 1 (KLF1) is a protein
from Homo sapiens identified by UniProt accession
Q13351, 362 residues long.
MolForge cross-references it against 0 known binders and
276 disease associations.
Target properties
| Protein name | Krueppel-like factor 1 |
| UniProt accession | Q13351 |
| Gene | KLF1 |
| Organism | Homo sapiens |
| Length | 362 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (276)
Diseases linked to this target (Open Targets).
- congenital dyserythropoietic anemia type 4 · score 0.77
- mean corpuscular volume · score 0.69
- Congenital dyserythropoietic anemia type IV · score 0.69
- mean corpuscular hemoglobin · score 0.66
- Red cell distribution width · score 0.65
- erythrocyte count · score 0.55
- hereditary persistence of fetal hemoglobin-sickle cell disease syndrome · score 0.54
- mean corpuscular hemoglobin concentration · score 0.52
- hemoglobin measurement · score 0.50
- Hydrops fetalis · score 0.46
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q13351-F1 | alphafold | PREDICTED | 56.98 | — |
Amino-acid sequence (362 residues)
MATAETALPS ISTLTALGPF PDTQDDFLKW WRSEEAQDMG PGPPDPTEPP LHVKSEDQPG EEEDDERGAD ATWDLDLLLT NFSGPEPGGA PQTCALAPSE ASGAQYPPPP ETLGAYAGGP GLVAGLLGSE DHSGWVRPAL RARAPDAFVG PALAPAPAPE PKALALQPVY PGPGAGSSGG YFPRTGLSVP AASGAPYGLL SGYPAMYPAP QYQGHFQLFR GLQGPAPGPA TSPSFLSCLG PGTVGTGLGG TAEDPGVIAE TAPSKRGRRS WARKRQAAHT CAHPGCGKSY TKSSHLKAHL RTHTGEKPYA CTWEGCGWRF ARSDELTRHY RKHTGQRPFR CQLCPRAFSR SDHLALHMKR HL
Explore Krueppel-like factor 1 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets